Skip to main content
. 2022 Jan 5;12:790415. doi: 10.3389/fimmu.2021.790415

Figure 2.

Figure 2

Antibody titers in pre-pandemic human plasma samples (N = 496; period 2016-2017). The IPMA titers for antibodies against HCoV-229E, HCoV-OC43, SARS-CoV-2 S and SARS-CoV-2 N of a panel of 496 pre-pandemic plasma samples are given in pie charts (left). For each slice, the absolute number of samples is added, except for two samples (having a titer <40 for OC43-IPMA or 2560 for S-IPMA). Twenty-four of these samples were selected and analysed for their SARS-CoV-2 neutralizing titer, as shown in the heatmap (right).